Efficacy and Safety of Lipid-Lowering Drugs of Different Intensity on Clinical Outcomes: A Systematic Review and Network Meta-Analysis

There have been many meta-analyses for statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) to evaluate clinical outcomes, but the efficacy and safety of different intensity of these three drugs on clinical outcomes was absent. PCSK9i, ezetimibe, and statins were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenrui, Pan, Qinyuan, Pan, Defeng, Xu, Tongda, Zhu, Hong, Li, Dongye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567017/
https://www.ncbi.nlm.nih.gov/pubmed/34744709
http://dx.doi.org/10.3389/fphar.2021.713007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567017/
https://www.ncbi.nlm.nih.gov/pubmed/34744709
http://dx.doi.org/10.3389/fphar.2021.713007

Ejemplares similares